๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pretreatment preparation and management of interferon-based therapy for hepatitis C virus infection

โœ Scribed by Max Hopwood; Carla Treloar


Book ID
108833378
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
63 KB
Volume
59
Category
Article
ISSN
0309-2402

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Depression and antiviral response to int
โœ Jennifer M. Loftis; Benjamin J. Morasco; Peter Hauser ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 378 KB ๐Ÿ‘ 1 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Interferon-ฮฑ therapy for hepatitis c vir
โœ Teresa L. Wright; Connie Combs; Michael Kim; Linda Ferrell; Peter Bacchetti; Nan ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 793 KB

The aims of this pilot study were to evaluate the safety and efficacy of interferon-alpha 2b for treatment of hepatitis C virus infection in liver transplant recipients, to monitor changes in hepatitis C virus RNA levels with treatment and to determine pretreatment parameters predictive of a complet

Pegylated interferon and ribavirin thera
โœ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-Saunรฉ; J.P. Vinel; L. A ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCVโ€4 responds poorly to interferon. Pegylated